about
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its pro...
Read More
1.77
-0.14
(-7.33%)
608.3K
XNAS Volume
XNAS 28 Aug, 2025 1:36 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Equillium Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..